Pfizer Inc. has joined COVIDRIVE

July, 01 2023 – Pfizer has joined the COVIDRIVE Consortium and officially become a COVIDRIVE partner. Pfizer will further contribute to the assessment of the effectiveness of vaccines in Europe.

With the inclusion of Pfizer, COVIDRIVE, which brings together public institutions, small and medium-sized enterprises, and vaccine companies, has a total of nine partners. COVIDRIVE’s first study focuses on COVID-19 vaccine effectiveness against hospitalisation and started in September 2021.

Leave a Reply

Your email address will not be published. Required fields are marked *